JOIN THE RACE

Sign in to save scores, appear on leaderboards and track personal bests.

Home Food Receipts Nutella vs Cheerios

Nutella VS Cheerios

Verdict DROP IT BUY IT
The Reality Plaintiffs, including a mother who fed the product to her 4-year-old daughter based on the balanced-breakfast messaging, sued after discovering each serving contained 21 grams of sugar, 200 calories, and 11 grams of fat (3.5 grams saturated). Ferrero settled the resulting class action for $3 million in 2012, agreeing to pay consumers $4 per jar (up to 5 jars each), remove the 'balanced breakfast' phrase from the back label entirely, replace it with 'Turn a balanced breakfast into a tasty one,' and submit future commercials for plaintiff approval before airing. On May 5, 2009, the FDA sent General Mills a formal warning letter finding these specific, quantified claims made Cheerios an unapproved new drug under federal law, since companies are legally barred from quantifying a specific percentage health benefit the way General Mills had. Critically, the underlying science itself wasn't in dispute: Cheerios' general soluble-fiber cholesterol-lowering claim had already been an FDA-authorized qualified health claim for 12 years at that point, and General Mills maintained the clinical study behind the 4% figure was genuinely strong. The issue the FDA flagged was specifically the precise quantification ('4% in 6 weeks'), not the broader, already-approved claim that whole-grain oat soluble fiber can help reduce cholesterol as part of a diet low in saturated fat.
SHORT ANSWER

Nutella: Ferrero paid $3 million in 2012 to settle a class-action lawsuit and removed the phrase 'balanced breakfast' from Nutella's labeling after plaintiffs pointed out a single serving carries 21 grams of sugar, 200 calories, and 11 grams of fat.

Cheerios: Cheerios' general claim that whole-grain oat soluble fiber can help lower cholesterol is a legitimate, FDA-authorized health claim with real science behind it -- but General Mills' specific 2009 quantified claim ('4% in 6 weeks') crossed into illegal, unapproved drug-claim territory and drew a formal FDA warning letter.